Clinical Trials Sponsored by IVascular

Total 374 results

iVascular S.L.U.

Not yet recruiting

Investigating the Safety and Clinical Performance of Eight iVascular Devices for Endovascular Intervention in Renal, Iliac or Femoral Arteries

Artery Disease

France
iVascular S.L.U.

Not yet recruiting

Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy (ANGIODAPT)

Coronary Artery Disease
iVascular S.L.U.

Recruiting

Prospective, Multicentre Study to Evaluate the Thrombectomy System for Stroke: INEDIT, INDEEP and INTERCEPT (SEMTiC)

Acute Ischemic Stroke

Spain, Belgium, France, Germany
iVascular S.L.U.

Recruiting

Efficacy and Safety Evaluation of the Thromboaspiration Catheter System iNstroke in Patients With Acute Ischemic Stroke (ASPiC)

Acute Ischemic Stroke

Spain
iVascular S.L.U.

Completed

Luminor Registry: Registry of the Results of Angioplasty With Drug-eluting Balloon (Paclitaxel) in the Treatment of Infrainguinal Occlusive Lesions and Restenosis From Prior Endovascular Procedures in This Sector.

Peripheral Vascular Disease

Spain
iVascular S.L.U.

Not yet recruiting

Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease (ILICO)

Peripheral Arterial Disease | Iliac Artery Disease | Angioplasty | Aorto-Iliac Atherosclerosis | Covered Stent

Belgium, Germany, France, Spain
iVascular S.L.U.

Recruiting

European All-comers' Multicentric Prospective REGISTRY on LUMINOR© Drug Eluting Balloon in the Superficial Femoral Artery and Popliteal Artery With 5 Years Follow-up. (LUMIFOLLOW)

Peripheral Arterial Disease | Angioplasty | Paclitaxel | Drug-eluting Balloon | Femoral Artery

France
Lake Washington Vascular
Medtronic Vascular

Unknown

Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES)

Varicose Veins | Venous Reflux

United States
LeMaitre Vascular

Recruiting

Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair

Heart Diseases

China
Medtronic Vascular

Completed

SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study

Cardiovascular Diseases | Vascular Diseases | Hypertension

United States, Canada, Germany, Australia, United Kingdom, Ireland, Japan, Austria, Greece
Basecamp Vascular

Completed

ACtive Catheterization for EndovaScular TreatmentS (ACCESS)

Carotid Stenosis | Unruptured Intracranial Aneurysm | Arteriovenous Cerebral Malformations

France
Medtronic Vascular

Completed

A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear) (Onyx ONE Clear)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

Medtronic RevElution Trial (RevElution)

Coronary Artery Disease

Australia, Singapore, Brazil
Medtronic Vascular

Completed

The PREVAIL Study (PREVAIL)

Coronary Artery Disease | Ischemic Heart Disease | In-stent Restenosis

Italy, Belgium, Netherlands
Medtronic Vascular

Completed

Medtronic Resolute Onyx 2.0 mm Clinical Study

Coronary Artery Disease

United States
Medtronic Vascular

Completed

Resolute Integrity US Extended Length Sub-Study(RI US XL) (RI-US XL)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System (RI-US)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension (HTN-J)

Uncontrolled Hypertension

Japan
Medtronic Vascular

Completed

The Medtronic RESOLUTE US Clinical Trial (R-US)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

Stable Angina Observational Registry (STAR)

Stable Angina

India
Medtronic Vascular

Completed

Sprinter Legend Balloon Catheter

Coronary Artery Disease

United States
Medtronic Vascular

Recruiting

Global SYMPLICITY Registry (GSR) DEFINE

Hypertension

Germany
Medtronic Vascular

Active, not recruiting

RESOLUTE ONYX China RCT Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
LeMaitre Vascular

Active, not recruiting

Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular Repair

Vascular Diseases

China
Medtronic Vascular

Completed

RESOLUTE ONYX Post-Approval Study (ONYX PAS)

Coronary Artery Disease

United States, Belgium, France, Slovakia
Medtronic Vascular

Completed

China Resolute Integrity 34/38 mm Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
LeMaitre Vascular

Active, not recruiting

LeMaitre LifeSpan® ePTFE Vascular Graft Retrospective Registry

Diseased or Occluded Blood Vessels | Arteriovenous Shunting for Blood Access

Germany
Pulsar Vascular

Terminated

A Study Evaluating the Safety and Effectiveness of the PulseRider® Aneurysm Neck Reconstruction Device Used in Conjunction With Endovascular Coil Embolization in the Treatment of Wide-Neck Bifurcation Intracranial Aneurysm (NAPA)

Unruptured Wide-neck Intracranial Aneurysms

United States
Vascular Cures

Completed

PREDICT-PVI Understanding Peripheral Restenosis: Genomic and Proteomic Determinants of Vascular Intervention

Peripheral Artery Disease

United States
Medtronic Vascular

Completed

A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients (Onyx ONE)

Coronary Artery Disease

Korea, Republic of, Spain, Australia, Hong Kong, United Kingdom, Singapore, Thailand, Belgium, New Zealand, Sweden, France, Switzerland, Netherlands, Italy, Slovakia, Lithuania, Austria, Malaysia, Bulgaria, Ireland, Latvia, Norway, ...
Pulsar Vascular

Completed

Adjunctive Neurovascular Support for Wide-neck Aneurysm Embolization and Reconstruction (ANSWER)

Intracranial Aneurysms

United States
Medtronic Vascular

Completed

Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study

Coronary Artery Disease

United States
Pulsar Vascular

Completed

Safety Study of the PulseRider® in Patients Undergoing Treatment for Bifurcation Intracranial Aneurysms (AWARD)

Brain Aneurysm

Austria
Medtronic Vascular

Completed

RESOLUTE China Registry: (R-C Registry)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

RESOLUTE China RCT (R-China RCT)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries (RJ-SVS)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Medtronic Vascular

Completed

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia (R-A)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Coronary Stenosis

India
Medtronic Vascular

Completed

Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2) (HTN-2)

Uncontrolled Hypertension

Spain, Australia, Germany, France, Latvia, United Kingdom, Belgium, Austria, Poland, Switzerland
Medtronic Vascular

Completed

PROTECT Continued Access Post Marketing Surveillance Trial (PROTECT-CA)

Coronary Artery Disease, Autosomal Dominant, 1

United States
Medtronic Vascular

Completed

Renal Denervation in Patients With Refractory Hypertension

Hypertension

Australia, Poland
Medtronic Vascular

Completed

Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

Kidney Failure, Chronic | Renal Dialysis

United States
Medtronic Vascular

Completed

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System (ENDEAVOR PK)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions (ENDEAVOR IV)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

The Medtronic RESOLUTE Clinical Trial

Coronary Artery Disease

Australia
Medtronic Vascular

Completed

The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial (ENDEAVOR III)

Coronary Artery Disease
Medtronic Vascular

Completed

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions (ENDEAVOR II)

Ischemia | Myocardial Ischemia | Heart Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Arteriosclerosis

France
LeMaitre Vascular

Terminated

Study to Evaluate the Performance and Safety of Expedial and Compare it to Expanded Polytetrafluoroethylene (ePTFE) Vascular Access Grafts

End Stage Renal Disease

United States
Medtronic Vascular

Recruiting

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Cardiovascular Diseases | Vascular Diseases | Hypertension | Diabetes Mellitus | Chronic Kidney Diseases

United States, Monaco, Australia, Germany, France, United Kingdom, Belgium, Netherlands, Sweden, Greece
Medtronic Vascular

Completed

SPYRAL DYSTAL Renal Denervation Global Clinical Study

Cardiovascular Diseases | Vascular Diseases | Hypertension

United States, United Kingdom, Germany, Greece
Medtronic Vascular

Active, not recruiting

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

Cardiovascular Diseases | Vascular Diseases | Hypertension

United States, Germany, Canada, Australia, United Kingdom, France, Ireland, Japan, Austria, Greece

Clinical Trials Sponsored by IVascular

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations